[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100651861":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":13,"locations":20,"responsibleParty":42,"collaborators":7,"id":45,"slug":46,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":7,"eligibilityCriteria":51,"healthyVolunteers":47,"sex":52,"minAge":53,"maxAge":7,"enrollmentInfo":54,"targetDuration":57,"studyType":58,"phases":7,"briefSummary":59,"conditions":60,"keywords":63,"overallStatus":68,"whyStopped":7,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"Kutahya Health Sciences University","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DIAGNOSTIC_TEST","Pain classification method","A current clinical algorithm will be used to determine the predominant type of pain in individuals with MS. The classification to diagnose nociceptive, neuropathic and nociplastic pain will based on a recent method developed by Nijs et al. This method consists of seven steps in total. These steps question the following, respectively: duration of pain, pain distribution, presence of nociceptive pain, presence of neuropathic pain, phenomenon of hypersensitivity, presence of hypersensitization and presence of specific comorbidity. Besides, inter-rater and intra-rater reliability of pain classification algorithm will be determined by two independent researchers.",[14],{"name":15,"role":16,"phone":17,"phoneExt":18,"email":19},"Nisa TURUTGEN, Msc.","CONTACT","00902742651300","1499","nisa.turutgen@ksbu.edu.tr",[21],{"facility":22,"status":7,"city":23,"state":24,"zip":25,"country":26,"countryCode":7,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"Kutahya Health Sciences University Physical Medicine and Rehabilitation Department","Kütahya","Turkiye","43100","Turkey (Türkiye)",{"type":28,"coordinates":29},"Point",[30,31],29.98333,39.42417,{"lat":31,"lon":30},[34,38,40],{"name":35,"role":16,"phone":36,"phoneExt":18,"email":37},"Ismail SARACOGLU, Head of Department","002742651300","ismail.saracoglu@ksbu.edu.tr",{"name":15,"role":39,"phone":7,"phoneExt":7,"email":7},"PRINCIPAL_INVESTIGATOR",{"name":41,"role":39,"phone":7,"phoneExt":7,"email":7},"Dursun CEYLAN, MD",{"type":39,"investigatorFullName":43,"investigatorTitle":44,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Ismail Saracoglu","Head of Department","100651861","pain-phenotypes-in-individuals-with-multiple-sclerosis-100651861",false,"NCT07766213","Pain Phenotypes in Individuals With Multiple Sclerosis","Pain Phenotyping in Multiple Sclerosis Based on IASP Criteria","Inclusion Criteria:\n\n* Age 18 years or older\n* Definite diagnosis of multiple sclerosis according to the McDonald criteria\n* No MS relapse or high-dose steroid treatment within the previous 3 months\n* Pain intensity ≥2 on the Numeric Rating Scale in at least one body region for at least 3 months\n* Ability to read, understand, and communicate in Turkish\n\nExclusion Criteria:\n\n* Pregnancy\n* Severe psychiatric disorder and\u002For severe cognitive impairment confirmed by a neurologist or neuropsychiatrist\n* Presence of a serious pathology or disease that may compromise the assessment process or affect clinical decision-making, including metastasis, cancer, untreated or unhealed fractures, neurological disorders other than multiple sclerosis, or a history of diabetes","ALL","18 Years",{"count":55,"type":56},60,"ESTIMATED","1 Day","OBSERVATIONAL","This observational cross-sectional study aims to determine chronic pain phenotypes in individuals with multiple sclerosis (MS) and to investigate the clinical characteristics associated with different pain phenotypes. Participants with MS and chronic pain will undergo a comprehensive clinical assessment to identify nociceptive, neuropathic, nociplastic, and mixed pain phenotypes. The assessment will include clinical history, pain characteristics and distribution, quantitative sensory testing, pain intensity, disease severity, fatigue, health-related quality of life, and pain catastrophizing. The clinical characteristics of participants with different pain phenotypes will subsequently be compared.",[61,62],"Multiple Sclerosis","Chronic Pain",[64,65,66,67],"CHRONIC PAIN","NEUROPATHIC PAIN","NOCIPLASTIC PAIN","MULTIPLE SCLEROSIS","NOT_YET_RECRUITING","2026-08-14",{"date":71,"type":72},"2026-08-18","ACTUAL",{"date":74,"type":56},"2026-08-15",{"date":76,"type":56},"2027-09-15",{"name":5,"class":6},1]